<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:department>Norwich Medical School</gtr:department><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F565225A-166A-4E10-8450-30E9A90D7789"><gtr:id>F565225A-166A-4E10-8450-30E9A90D7789</gtr:id><gtr:firstName>Eugene</gtr:firstName><gtr:otherNames>Vincent</gtr:otherNames><gtr:surname>McCloskey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/46FA670E-EDFC-4A96-BC70-65B378DCC6B4"><gtr:id>46FA670E-EDFC-4A96-BC70-65B378DCC6B4</gtr:id><gtr:firstName>Amanda</gtr:firstName><gtr:surname>Howe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D6B48D18-61EF-4F6C-B123-2CFE781FF2CD"><gtr:id>D6B48D18-61EF-4F6C-B123-2CFE781FF2CD</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Kanis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F1EB0967-3F9B-47F4-9AB2-67E9BAC6AC40"><gtr:id>F1EB0967-3F9B-47F4-9AB2-67E9BAC6AC40</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Holland</gtr:surname><gtr:orcidId>0000-0002-4663-6923</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C9E8964-E317-44D9-9833-EB9C7D2DE4D6"><gtr:id>6C9E8964-E317-44D9-9833-EB9C7D2DE4D6</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Gittoes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23B9BADA-AA4D-4A66-B85D-69D165BF6329"><gtr:id>23B9BADA-AA4D-4A66-B85D-69D165BF6329</gtr:id><gtr:firstName>Terence</gtr:firstName><gtr:surname>O'Neill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4F75A327-5E17-4390-8BFB-73A25E3FDD7D"><gtr:id>4F75A327-5E17-4390-8BFB-73A25E3FDD7D</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Fordham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7F34FE4F-554B-4465-9983-45FAC6D03DE2"><gtr:id>7F34FE4F-554B-4465-9983-45FAC6D03DE2</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Heawood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FAF47FFA-BCD4-484C-A17A-D74C4E8D77A6"><gtr:id>FAF47FFA-BCD4-484C-A17A-D74C4E8D77A6</gtr:id><gtr:firstName>Lee</gtr:firstName><gtr:surname>Shepstone</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EA2F586A-F0AF-4CC1-A4DB-876C3C335071"><gtr:id>EA2F586A-F0AF-4CC1-A4DB-876C3C335071</gtr:id><gtr:firstName>Cyrus</gtr:firstName><gtr:surname>Cooper</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5FD799DA-DA97-455D-AA31-4A380275AA9D"><gtr:id>5FD799DA-DA97-455D-AA31-4A380275AA9D</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Torgerson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/76FC6962-8CDC-4ACB-96BE-F9FB63D9B0DA"><gtr:id>76FC6962-8CDC-4ACB-96BE-F9FB63D9B0DA</gtr:id><gtr:firstName>Timothy James</gtr:firstName><gtr:surname>Peters</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7D86B369-782B-4E83-856C-7E353E985EC1"><gtr:id>7D86B369-782B-4E83-856C-7E353E985EC1</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Harvey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FB4F701D-83BF-4117-8207-889CC81F79AC"><gtr:id>FB4F701D-83BF-4117-8207-889CC81F79AC</gtr:id><gtr:firstName>Tarnya</gtr:firstName><gtr:surname>Marshall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601019"><gtr:id>48B0AB33-5330-45D7-A067-15DFAE504555</gtr:id><gtr:title>A pragmatic randomised controlled trial of screening for osteoporosis in older women</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601019</gtr:grantReference><gtr:abstractText>Osteoporosis is a common disease affecting around 20% of women aged over 50 years. The condition causes a ?thinning? of the bones making a sufferer prone to fractures. These fractures, particularly hip fractures, can lead to disability, a loss of independent living and even death. Current treatment for osteoporosis can reduce the risk of fracture by around 35% to 50%. However, predicting which women are at high risk of fracture and therefore would most likely benefit from treatment has so far not been conducted in a comprehensive and systematic manner. This study sets out to trial a method of screening all women aged between 70 and 85 for risk of fracture. Women in that age group recruited to the study will either be screened or managed as usual. Those screened and considered at high risk will be offered treatment by their GPs. All women will be followed for 5 years and, at the end of that period, a comparison of the fractures in the screened group will be made with those in the non-screened group. It is hoped that screening will reduce the number of fractures by around 20%.</gtr:abstractText><gtr:technicalSummary>The proposed randomised controlled trial aims to evaluate the effectiveness and cost-effectiveness of a community based screening program for osteoporosis in women aged 70 to 85. Those women randomised to the screening arm of the trial will provide information on clinical risk factors followed by bone mineral density (BMD) measurements where this information would be deemed useful. Based upon this information, a 10-year absolute risk for fracture will be calculated. This information will be given to study subjects? GPs with an indication of whether this risk exceeds a pre-determined treatment threshold or not. Those women in the control arm will be treated ?as usual?. The primary effiacy outcome, to be ascertained from hospital records will be fracture at any site. The follow up period will be 5 years and a sample size of 11 500 women will be sufficient to provided 90% power to detect a 18% relative reduction in fractures.</gtr:technicalSummary><gtr:fund><gtr:end>2015-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3724978</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Osteoporosis Information Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DF268E99-E9DA-4695-8F34-B6FE42070A25</gtr:id><gtr:impact>Around 100 people for the local area with an interest in osteoporosis. Organised by the local trust and local NOS.

Impossible to say.</gtr:impact><gtr:outcomeId>hk25Jun3cj7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>152839</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research for Patient Benefit</gtr:department><gtr:description>NIHR Research for Patient Benefit</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F6900C10-E6F1-4DC7-BBB4-5225A478DE6B</gtr:id><gtr:outcomeId>865BB8C21960</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180384</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Efficacy and Mechanisms Evaluation</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>G0601019</gtr:fundingRef><gtr:id>50C91E1A-27CC-42F8-A500-C640F395047B</gtr:id><gtr:outcomeId>m9kNx5EGkfw</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The SCOOP trial has provide a database of over 12000 older women followed up for more than 5 years. These have been recruited from the general community (rather than disease or condition specific) and have comprehensive data on osteoporosis medications and fractures, amongst other things. This should prove a good asset for future work.</gtr:description><gtr:id>F43B7FA6-90DC-44F2-B7D0-8FAB5A8AD65B</gtr:id><gtr:impact>None to date but this database will be of use to other groups once the trial and associated papers are complete.

Data are now being released to the wider research team to pursue secondary research questions. In addition, an application has been submitted to the HTA for further funding to keep data collection going for a further five years. If successful this will be a very valuable database.</gtr:impact><gtr:outcomeId>5460ada4b0f875.46128949</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SCOOP cohort database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The SCOOP RCT has used an approach to data collection for fracture outcome that is being duplicated in at least one other RCT. It makes use of self-report and readily available data through the NHS.</gtr:description><gtr:id>DAE88C6D-2655-4382-BE24-41D6E5909B5B</gtr:id><gtr:impact>Little at present. Now being used by another trial and, informally, suggested as the main method for the primary outcome data collection for a second.</gtr:impact><gtr:outcomeId>5460acef22adc9.32767327</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Fracture data collection methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>105E20A7-D892-4411-A49B-80CF26D9FEC8</gtr:id><gtr:title>Prior notification of trial participants by newsletter increased response rates: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e53001552458977bcd54060ad6c6ae6"><gtr:id>0e53001552458977bcd54060ad6c6ae6</gtr:id><gtr:otherNames>Mitchell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>NagJ7viR1y7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90B42A0E-BFEA-47EA-8BD5-DB5E8F9D22C1</gtr:id><gtr:title>A controlled trial of envelope colour for increasing response rates in older women</gtr:title><gtr:parentPublicationTitle>AGING CLINICAL AND EXPERIMENTAL RESEARCH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5902e9239c633567b9573b105f386a"><gtr:id>1d5902e9239c633567b9573b105f386a</gtr:id><gtr:otherNames>Mitchell Natasha</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1594-0667</gtr:issn><gtr:outcomeId>5a360e5d305f41.95859300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DEF7706-71DA-458B-B22E-8E668C2E0A49</gtr:id><gtr:title>The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f5401e07b1f28cc26f50d770bb42e18"><gtr:id>9f5401e07b1f28cc26f50d770bb42e18</gtr:id><gtr:otherNames>Turner DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>5aa28f929ca227.25784907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183BFE4E-7AE3-4017-BE6F-28EB90AA61DF</gtr:id><gtr:title>Enclosing a pen reduced time to response to questionnaire mailings.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e521aa1d866caa7f5aac791b371b2d8"><gtr:id>6e521aa1d866caa7f5aac791b371b2d8</gtr:id><gtr:otherNames>Bell K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn><gtr:outcomeId>56dea32e0bf061.87604885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78726F32-3ECD-4624-9B09-6191DCC99A0B</gtr:id><gtr:title>Acceptability of screening to prevent osteoporotic fractures: a qualitative study with older women.</gtr:title><gtr:parentPublicationTitle>Family practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48f52332c985f75a305ee7335f5f1af6"><gtr:id>48f52332c985f75a305ee7335f5f1af6</gtr:id><gtr:otherNames>Emmett CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0263-2136</gtr:issn><gtr:outcomeId>Ma4UaFYHjMR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6404780C-50C0-4463-BAF6-C366006A2A3A</gtr:id><gtr:title>Risk, significance and biomedicalisation of a new population: older women's experience of osteoporosis screening.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3298c07fe5e1fc8fe7e9f355a1639d6"><gtr:id>a3298c07fe5e1fc8fe7e9f355a1639d6</gtr:id><gtr:otherNames>Salter CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>sgrLzYUkPTC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ADC75D8-03AD-4405-9365-276F4B64CD24</gtr:id><gtr:title>Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d7bc3460ca4d1e9e97826849c5bfae7"><gtr:id>9d7bc3460ca4d1e9e97826849c5bfae7</gtr:id><gtr:otherNames>Shepstone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5aa28ef89686d7.89489269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE4EEF6A-E5D3-4A89-964E-87E0B24F4E4B</gtr:id><gtr:title>Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures - a post hoc analysis of the SCOOP Study.</gtr:title><gtr:parentPublicationTitle>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b7e848d77adc15bae9bb1f7234789d7"><gtr:id>3b7e848d77adc15bae9bb1f7234789d7</gtr:id><gtr:otherNames>McCloskey E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0884-0431</gtr:issn><gtr:outcomeId>5aa28f4874bf64.29897557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10649C03-473D-4620-90D5-42F9B46A3415</gtr:id><gtr:title>A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study.</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d7bc3460ca4d1e9e97826849c5bfae7"><gtr:id>9d7bc3460ca4d1e9e97826849c5bfae7</gtr:id><gtr:otherNames>Shepstone L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn><gtr:outcomeId>XPsgACcf3FU</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601019</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5C2ACE0A-A29E-4DCC-9F5A-B00BFAB172B9</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.4  Population screening</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>